Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CapsoVision, Inc. before investing.
In this article, we go over a few key elements for understanding CapsoVision, Inc.’s stock price such as:
- CapsoVision, Inc.’s current stock price and volume
- Why CapsoVision, Inc.’s stock price changed recently
- Upgrades and downgrades for CV from analysts
- CV’s stock price momentum as measured by its relative strength
About CapsoVision, Inc. (CV)
Before we jump into CapsoVision, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Want to learn more about CapsoVision, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about CapsoVision, Inc..
CapsoVision, Inc.’s Stock Price as of Market Close
As of October 09, 2026, 4:00 PM, CST, CapsoVision, Inc.’s stock price was $6.590.
CapsoVision, Inc. is down 0.45% from its previous closing price of $6.620.
During the last market session, CapsoVision, Inc.’s stock traded between $6.535 and $6.730. Currently, there are approximately 49.94 million shares outstanding for CapsoVision, Inc..
CapsoVision, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.
CapsoVision, Inc. Stock Price History
CapsoVision, Inc.’s (CV) price is currently up 2.01% so far this month.
During the month of October, CapsoVision, Inc.’s stock price has reached a high of $6.730 and a low of $6.110.
Over the last year, CapsoVision, Inc. has hit prices as high as $15.370 and as low as $4.380. Year to date, CapsoVision, Inc.’s stock is down 38.35%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused CapsoVision, Inc. Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of October 09, 2026, there were analysts who downgraded CapsoVision, Inc.’s stock and analysts who upgraded over the last month.
Additionally, you'll want to evaluate CapsoVision, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on CapsoVision, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
CapsoVision, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about CapsoVision, Inc. (CV) by visiting AAII Stock Evaluator.
Relative Price Strength of CapsoVision, Inc.
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of October 09, 2026, CapsoVision, Inc. has a weighted four-quarter relative price strength of 4.83%, which translates to a Momentum Score of 76 and is considered to be Strong.
Want to learn more about how CapsoVision, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
CapsoVision, Inc. Stock Price: Bottom Line
As of October 9, 2026, CapsoVision, Inc.’s stock price is $6.590, which is down 0.45% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like CapsoVision, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Yield Screen: 8.7% Compared to S&P 500
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.